These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25431327)

  • 1. Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?
    Heimans L; Wevers-deBoer KV; Ronday HK; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Clin Rheumatol; 2015 Jan; 34(1):163-6. PubMed ID: 25431327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of matrices in daily clinical practice to predict rapid radiologic progression in patients with early RA.
    De Cock D; Vanderschueren G; Meyfroidt S; Joly J; Van der Elst K; Westhovens R; Verschueren P
    Semin Arthritis Rheum; 2014 Apr; 43(5):627-31. PubMed ID: 24200124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.
    Visser K; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ronday HK; Seys PE; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Jul; 69(7):1333-7. PubMed ID: 20498212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
    Vastesaeger N; Xu S; Aletaha D; St Clair EW; Smolen JS
    Rheumatology (Oxford); 2009 Sep; 48(9):1114-21. PubMed ID: 19589891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
    Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
    Klarenbeek NB; Güler-Yüksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Dec; 69(12):2107-13. PubMed ID: 20610442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.
    Baker JF; Conaghan PG; Emery P; Baker DG; Østergaard M
    Ann Rheum Dis; 2016 Jun; 75(6):1114-9. PubMed ID: 26091907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.
    Fautrel B; Granger B; Combe B; Saraux A; Guillemin F; Le Loet X
    Arthritis Res Ther; 2012 Nov; 14(6):R249. PubMed ID: 23164197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
    Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated joint space width quantification of hand and wrist joints: a proof of concept study.
    Huo Y; Veldhuizen RD; van der Heijde DM; Besselink NJ; Jacobs JW; van Laar JM; Viergever MA; Vincken KL; Lafeber FP; de Hair MJ;
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S34-S39. PubMed ID: 27762190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis].
    Avdeeva AS; Aleksandrova EN; Karateev DE; Panasyuk EY; Smirnov AV; Cherkasova MV; Nasonov EL
    Ter Arkh; 2016; 88(5):13-18. PubMed ID: 27239921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.
    Wevers-de Boer KV; Heimans L; Visser K; Kälvesten J; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman M; de Buck MP; de Sonnaville PB; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2015 Feb; 74(2):341-6. PubMed ID: 24285491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.
    Meeuwisse CM; van der Linden MP; Rullmann TA; Allaart CF; Nelissen R; Huizinga TW; Garritsen A; Toes RE; van Schaik R; van der Helm-van Mil AH
    Arthritis Rheum; 2011 May; 63(5):1265-73. PubMed ID: 21305530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
    Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2014 Jul; 73(7):1356-61. PubMed ID: 23716067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases.
    Vanier A; Smolen JS; Allaart CF; Van Vollenhoven R; Verschueren P; Vastesaeger N; Saevarsdottir S; Visser K; Aletaha D; Combe B; Fautrel B
    Rheumatology (Oxford); 2020 Aug; 59(8):1842-1852. PubMed ID: 31722413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis.
    Terao C; Yamakawa N; Yano K; Markusse IM; Ikari K; Yoshida S; Furu M; Hashimoto M; Ito H; Fujii T; Ohmura K; Murakami K; Takahashi M; Hamaguchi M; Tabara Y; Taniguchi A; Momohara S; Raychaudhuri S; Allaart CF; Yamanaka H; Mimori T; Matsuda F
    Arthritis Rheumatol; 2015 Dec; 67(12):3113-23. PubMed ID: 26245322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
    Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A
    Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'.
    Koevoets R; Dirven L; Klarenbeek NB; van Krugten MV; Ronday HK; van der Heijde DM; Huizinga TW; Kerstens PS; Lems WF; Allaart CF
    Ann Rheum Dis; 2013 Jun; 72(6):870-4. PubMed ID: 22753403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.